These findings suggest that the genetic variants which lead to low LDL cholesterol and apo B‐containing lipoproteins may have a role in histological progression among patients diagnosed with MASLD independent of previously known common genetic variants. Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.